1,132 research outputs found
Three-Dimensional Bar Structure and Disc/Bulge Secular Evolution
Kn-band imaging of a sample of 30 edge-on spiral galaxies with a boxy or
peanut-shaped (B/PS) bulge is discussed. Galaxies with a B/PS bulge tend to
have a more complex morphology than galaxies with other bulge types,
unsharp-masked images revealing structures that trace the major orbit families
of three-dimensional bars. Their surface brightness profiles are also more
complex, typically containing 3 or more clearly separated regions, including a
shallow or flat intermediate region (Freeman Type II profiles), suggestive of
bar-driven transfer of angular momentum and radial redistribution of material.
The data also suggest abrupt variations of the discs' scaleheights, as expected
from the vertical resonances and instabilities present in barred discs but
contrary to conventional wisdom. Counter to the standard `bulge + disc' model,
we thus propose that galaxies with a B/PS bulge are composed of a thin
concentrated disc (a disc-like bulge) contained within a partially thick bar
(the B/PS bulge), itself contained within a thin outer disc. The inner disc
most likely formed through bar-driven processes while the thick bar arises from
buckling instabilities. Both are strongly coupled dynamically and are formed
mostly of the same (disc) material.Comment: 6 pages, including 1 figure. To appear in "Island Universes:
Structure and Evolution of Disk Galaxies", ed. R. de Jong (Springer:
Dordrecht
The Roof is Leaking and a Storm is Raging:Repairing the Blood-Brain Barrier in the Fight Against Epilepsy
Editorial: epilepsy and neurodevelopmental diseases
The association between epilepsy and neurodevelopmental diseases is well-recognized and has gained significant attention in the field of neuroscience in recent years. One of the main reasons for this interest is the need for a better understanding of the events that lead to the development and maturation of the CNS. This is a fundamental and necessary basis for potential breakthrough strategies that could guide novel and more effective disease-modifying therapeutic approaches to neurodevelopmental syndromes that are frequently characterized by severe and
drug-resistant epilepsy. The perspective of such new therapeutic strategies is very promising. At the state-of-theart, patients afflicted by these rare neurodevelopmental disorders mostly rely on “symptomatic” approaches that mitigate seizures and other major symptoms but do not target the underlying biological causes of the disease.
The study of this vast field of research is extremely complex and requires a multidisciplinary approach, from neuropathological to molecular and functional studies since even “simple” triggering events (e.g., a genetic mutation) during critical periods of brain development can lead to widespread effects on brain morphological and functional features
Systematic review and meta-analysis of differentially expressed miRNAs in experimental and human temporal lobe epilepsy
LINC00507 Is Specifically Expressed in the Primate Cortex and Has Age-Dependent Expression Patterns
Over the past decade, there has been an increase in the appreciation of the role of non-coding RNA in the development of organism phenotype. It is possible to divide the non-coding elements of the transcriptome into three categories: short non-coding RNAs, circular RNAs and long non-coding RNAs. Long non-coding RNAs are those transcripts that are greater than 200 nts in length and lack any significant open reading frames that produce proteins greater then 100 amino acids. Long intervening non-coding RNAs (lincRNAs) are a subclass of long non-coding RNAs. In contrast to protein coding RNAs, lincRNAs are expressed in a more tissue- and species-specific manner. In particular, many lincRNAs are only conserved amongst higher primates. This coupled with the propensity of many lincRNAs to be expressed in the brain, suggests that they are in fact one of the major drivers of organism complexity. We analysed 39 lincRNAs that are expressed in the frontal cortex and identified LINC00507 as being expressed in a cortex-specific manner in non-human primates and humans. The expression patterns of LINC00507 appear to be age-dependent, suggesting it may be involved in brain development of higher primates. Moreover, the analysis of LINC00507 potential to bind ribosomes revealed that this previously identified non-coding transcript may harbour a micropeptide
Phytocannabinoids in Neurological Diseases:Could They Restore a Physiological GABAergic Transmission?
Calcineurin controls expression of EAAT1/GLAST in mouse and human cultured astrocytes through dynamic regulation of protein synthesis and degradation
Alterations in the expression of glutamate/aspartate transporter (GLAST) have been associated with several neuropathological conditions including Alzheimer\u2019s disease and epilepsy. However, the mechanisms by which GLAST expression is altered are poorly understood. Here we used a combination of pharmacological and genetic approaches coupled with quantitative PCR and Western blot to investigate the mechanism of the regulation of GLAST expression by a Ca2+ /calmodulin-activated phosphatase calcineurin (CaN). We show that treatment of cultured hippocampal mouse and fetal human astrocytes with a CaN inhibitor FK506 resulted in a dynamic modulation of GLAST protein expression, being downregulated after 24\u201348 h, but upregulated after 7 days of continuous FK506 (200 nM) treatment. Protein synthesis, as assessed by puromycin incorporation in neo-synthesized polypeptides, was inhibited already after 1 h of FK506 treatment, while the use of a proteasome inhibitor MG132 (1 \ub5M) shows that GLAST protein degradation was only suppressed after 7 days of FK506 treatment. In astrocytes with constitutive genetic ablation of CaN both protein synthesis and degradation were significantly inhibited. Taken together, our data suggest that, in cultured astrocytes, CaN controls GLAST expression at a posttranscriptional level through regulation of GLAST protein synthesis and degradation
Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex
- …